Stay updated on Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.

Latest updates to the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page
- Check4 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; this appears to be a backend/maintenance update with no visible changes to study details or page content.SummaryDifference0.0%

- Check47 days agoChange DetectedFooter revision updated from v3.4.2 to v3.4.3. No substantive study information appears to be altered.SummaryDifference0.0%

- Check69 days agoChange DetectedA revision tag was updated from v3.4.1 to v3.4.2, indicating a backend/content-management update with no evident impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check76 days agoChange DetectedRevision: v3.4.1 was added and the previous v3.4.0 revision was removed, indicating a minor update to the page's version. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check90 days agoChange DetectedMinor UI and metadata tweaks, including displaying the glossary, a capitalization change to QC criteria wording, the No FEAR Act label variation, and a new site revision tag (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Galunisertib with Nivolumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galunisertib with Nivolumab in Solid Tumors Clinical Trial page.